Daratumumab-induced transient myopic shift

PURPOSE: To describe an unprecedented case of transient myopic shift induced by a chemotherapeutic agent, daratumumab. OBSERVATIONS: A 43-year-old emmetropic female with multiple myeloma experienced sudden onset of myopic shift during her first intravenous dose of daratumumab, an increasingly common...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavrommatis, Maria A., Jung, Hoon, Chari, Ajai, Barlogie, Bart, Chelnis, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312830/
https://www.ncbi.nlm.nih.gov/pubmed/30619976
http://dx.doi.org/10.1016/j.ajoc.2018.12.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312830/
https://www.ncbi.nlm.nih.gov/pubmed/30619976
http://dx.doi.org/10.1016/j.ajoc.2018.12.017

Ejemplares similares